Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2023 Earnings Call Transcript August 2, 2023
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.64, expectations were $0.54.
Operator: Hello, and welcome to the Q2 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I’ll be coordinating the call today. [Operator instructions]. I’ll now hand over to your host, Ran Meir, head of Investor Relations. Please go ahead.
Ran...
